Literature DB >> 22079382

Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential.

Lorenzo Montanaro1, Davide Treré, Massimo Derenzini.   

Abstract

Many human pathological conditions, not linked to genetic alterations of oncogenes or tumor suppressors, are nevertheless associated with an increased risk of developing cancer, and some of them are characterized by quantitative and/or qualitative changes in ribosome biogenesis. Indeed, there is evidence that both an up-regulation of ribosome biogenesis, such as that occurring during the abnormal stimulation of cell growth, and intrinsic dysfunctions of ribosomes, such as those characterizing a series of inherited disorders, show an increased incidence of tumor onset. Here we discuss some recent insights into the mechanisms by which these alterations in ribosome biogenesis may facilitate tumorigenesis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079382     DOI: 10.1016/j.bbcan.2011.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Motoring toward pre-60S-ribosome export.

Authors:  Vadim Shchepachev; David Tollervey
Journal:  Nat Struct Mol Biol       Date:  2016-01       Impact factor: 15.369

2.  Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.

Authors:  Julie M Madden; Kelly L Mueller; Aliccia Bollig-Fischer; Paul Stemmer; Raymond R Mattingly; Julie L Boerner
Journal:  Breast Cancer Res Treat       Date:  2014-08-17       Impact factor: 4.872

Review 3.  Ribosome biogenesis: emerging evidence for a central role in the regulation of skeletal muscle mass.

Authors:  Thomas Chaillou; Tyler J Kirby; John J McCarthy
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

4.  Identification of differentially expressed molecular functions associated with breast cancer using Gibbs sampling.

Authors:  Gang Zhou; Ming-Qian Lu; Dao-Jun Li; Bao-An Gao; Rong Guo
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

5.  RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.

Authors:  Hans C Lee; Hua Wang; Veerabhadran Baladandayuthapani; Heather Lin; Jin He; Richard J Jones; Isere Kuiatse; Dongmin Gu; Zhiqiang Wang; Wencai Ma; John Lim; Sean O'Brien; Jonathan Keats; Jing Yang; Richard E Davis; Robert Z Orlowski
Journal:  Br J Haematol       Date:  2017-04       Impact factor: 6.998

6.  The von Hippel-Lindau protein pVHL inhibits ribosome biogenesis and protein synthesis.

Authors:  Wen-Ting Zhao; Cheng-Fu Zhou; Xue-Bing Li; Yun-Fang Zhang; Li Fan; Jerry Pelletier; Jing Fang
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Thyroid cancer cell lines: an overview.

Authors:  Manuel Saiselet; Sébastien Floor; Maxime Tarabichi; Geneviève Dom; Aline Hébrant; Wilma C G van Staveren; Carine Maenhaut
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-16       Impact factor: 5.555

8.  MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.

Authors:  L F Gao; S Jia; Q M Zhang; Y F Xia; C J Li; Y H Li
Journal:  Clin Transl Oncol       Date:  2021-07-27       Impact factor: 3.405

9.  Active regulator of SIRT1 is required for ribosome biogenesis and function.

Authors:  John R P Knight; Anne E Willis; Jo Milner
Journal:  Nucleic Acids Res       Date:  2013-03-05       Impact factor: 16.971

10.  The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome Pathway.

Authors:  Kadri Õunap; Lilian Leetsi; Maarja Matsoo; Reet Kurg
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.